Labarai
Zhonghan Biomedical Technology (R) -2- (2, 5-difluorophenyl) pyrrolidine hanyar shirya patent an ba da izini bisa hukuma
Zhonghan (Qihe County) Biomedical Technology Co., Ltd. ya yi maraba da labari mai daɗi! A ranar 14 ga Yuni, 2024, Ofishin Hannun Hannu na Jiha a hukumance ya ba da sanarwa a hukumance yana sanar da cewa an sami nasarar ba da izinin izinin kamfani na hanyar shiri na (R) -2- (2, 5-difluorophenyl) pyrrolidine.
An zaɓi kamfanin a matsayin wani aiki don haɓaka ƙarfin ƙirƙira na kanana da matsakaitan masana'antu na fasaha a lardin Shandong
A watan Nuwamba 2021, Kimiyya ta lardin Shandong ta ba da sanarwar na farko da ke samar da ilimin zamani na Shandong na 2021, da kuma Zhonghan (Qihe County) Fasaha ta Zamani Co., Ltd. an girmama shi.
Kamfanin ya wuce takaddun shaida na tsarin gudanarwa na ingancin ISO9001, yana ɗaukar ingantaccen gudanarwa zuwa sabon matakin
A cikin watan Yunin 2024, kamfanin ya sanar da cewa ya sake samun nasarar tsallake takardar shedar ingancin tsarin sarrafa ingancin ISO9001, biyo bayan takardar shedarsa a shekarar 2021. Wannan ya nuna gagarumin nasarorin da aka samu wajen gudanar da inganci tare da kara habaka gasa da matsayin kasuwa a masana'antar.